Evidence map›Paper›PMID 19174788›Full record

ArticleThe American journal of gastroenterology2009

Dissecting GI phenotype-genotype relationships in GERD and dyspepsia: an SNP here and an SNP there!

Janusz A Jankowski, Nicholas J Talley

Open access · greenAbstract readCommentEditorial
In one paragraph

Article in The American journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Review
  3. Functional dyspepsia.Therapeutic advances in gastroenterology · 2010
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Janusz A Jankowski
Nicholas J Talley
Mayo Clinic in Florida · USUniversity of London · GB

Funding

Antidepressant Therapy for Functional DyspepsiaU01DK065713 · NIDDK · MAYO CLINIC ROCHESTER · PI LOCKE, GILES RICHARD · 2005 to 2011
$5.0M
Cancer Research UK 4584NIDDK NIH HHS U01 DK065713NIDDK NIH HHS U01 DK65713
6 · The paper itself

Abstract

It is known that the predisposition to human disease is a mixture of inherited susceptibility and acquired exposure to environmental factors. Understanding gastrointestinal disease has indicated that germline adenomatous polyposis coli mutations predispose with a 99% certainty to colorectal cancer, whereas squamous esophageal cancer is caused by a combination of environmental exposures (including alcohol consumption, cigarette smoke, ingestion of contaminated preserved food) and/or infection (specifically with human papilloma virus), in most cases. Until now, despite the reasonably strong evidence for genetic risk from monozygotic twin studies for gastro-esophageal reflux disease (GERD), there have been no documented genetic targets in GERD. In this edition of the Journal, there is intriguing evidence that a common, single base-pair change in the secondary messenger gene GNbeta3 (i.e., a single-nucleotide polymorphism) may be important, perhaps through promoting abnormal perception of visceral pain in the esophagus. Other works link this genetic factor to functional dyspepsia, and these exciting preliminary lines of evidence are reviewed.

Indexed as

DyspepsiaGastroesophageal RefluxGenotypeHeterotrimeric GTP-Binding ProteinsHumansPhenotypePolymorphism, Single NucleotideG-protein beta3 subunitHeterotrimeric GTP-Binding Proteins

Identifiers

PMID19174788
PMCPMC3935284
OpenAlexW1981231816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.